Growth Metrics

Healthequity (HQY) Liabilities and Shareholders Equity (2016 - 2026)

Healthequity has reported Liabilities and Shareholders Equity over the past 13 years, most recently at $3.4 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity fell 1.98% year-over-year to $3.4 billion; the TTM value through Jan 2026 reached $13.6 billion, down 0.63%, while the annual FY2026 figure was $3.4 billion, 1.98% down from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $3.4 billion at Healthequity, down from $3.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $3.5 billion in Q3 2024 and troughed at $3.0 billion in Q2 2023.
  • A 5-year average of $3.2 billion and a median of $3.2 billion in 2024 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 14.64% in 2022 and fell as far as 3.06% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $3.1 billion in 2022, then rose by 0.94% to $3.1 billion in 2023, then increased by 12.76% to $3.5 billion in 2024, then decreased by 2.59% to $3.4 billion in 2025, then fell by 0.52% to $3.4 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for HQY at $3.4 billion in Q1 2026, $3.4 billion in Q4 2025, and $3.4 billion in Q3 2025.